Is Oxybenzone recalled?
26 FDA recalls mention Oxybenzone. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Oxybenzone.
Class III · Low risk Terminated Apr 29, 2022
Reason Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5%…
Class II · Moderate risk Ongoing Jul 14, 2021
Reason cGMP Deviations
Class II · Moderate risk Ongoing Jul 14, 2021
Reason cGMP Deviations
Class II · Moderate risk Ongoing Jul 14, 2021
Reason cGMP Deviations
Class II · Moderate risk Ongoing Jul 14, 2021
Reason cGMP Deviations
Class II · Moderate risk Terminated Oct 9, 2020
Reason GMP Deviations
Class II · Moderate risk Terminated Jun 13, 2020
Reason Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.
Class II · Moderate risk Terminated Jun 3, 2020
Reason Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.
Class II · Moderate risk Terminated Mar 3, 2020
Reason Superpotent drug: This lot of SPF containing lip balm contains up to 150% of the label claim for active ingredient Oxybenzone.
Class III · Low risk Terminated Apr 1, 2019
Reason CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
Class III · Low risk Terminated Apr 1, 2019
Reason CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
Class III · Low risk Terminated Dec 10, 2018
Reason Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
Class III · Low risk Terminated Dec 10, 2018
Reason Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
Class III · Low risk Terminated Aug 3, 2018
Reason Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.
Class III · Low risk Terminated Aug 3, 2018
Reason Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.
Class II · Moderate risk Terminated Feb 23, 2018
Reason Labeling: Label mix-up
Class II · Moderate risk Terminated Dec 20, 2017
Reason Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
Class II · Moderate risk Terminated Dec 20, 2017
Reason Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
Class II · Moderate risk Terminated Dec 14, 2017
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class II · Moderate risk Terminated Dec 14, 2017
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class II · Moderate risk Terminated Dec 14, 2017
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class II · Moderate risk Terminated Dec 14, 2017
Reason GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class II · Moderate risk Terminated Nov 28, 2017
Reason CGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.
Class II · Moderate risk Ongoing Mar 1, 2017
Reason Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.
Class II · Moderate risk Ongoing Oct 15, 2015
Reason cGMP Deviations; product does not comply with cGMP requirements